Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and New Era Energy & Digital, Inc. (NASDAQ: NUAI) (FKA New Era Helium (NASDAQ: NEHC)): Grabar Law Office is Investigating Claims on Your Behalf

Legal investigations dominate; no financial data or credible upside for investors is disclosed.

What the company is saying

The companies named—ADMA Biologics, GeneDx Holdings, Navan, and New Era Energy & Digital—are not directly communicating to investors in this announcement; instead, the narrative is constructed by Grabar Law Office, which is investigating alleged misconduct at each firm. The core message is that these companies, or their officers and directors, are accused of breaching fiduciary duties, making misleading statements, and failing to disclose material information, particularly around internal controls, related-party transactions, and business prospects. The language is legalistic and accusatory, emphasizing alleged failures in transparency, governance, and disclosure, and highlighting the potential for significant legal, regulatory, and financial consequences. The announcement foregrounds the existence of investigations, lawsuits, and specific allegations—such as channel-stuffing at ADMA, misleading statements about the Fabric acquisition at GeneDx, and a fraudulent oil-and-gas scheme at New Era—while omitting any discussion of operational achievements, financial performance, or business strategy from the companies themselves. The tone is stern, factual, and negative, with no attempt to reassure or promote the companies’ prospects. Notable individuals mentioned include Joshua H. Grabar, Esq., the attorney leading the investigations, and Everett Willard Gray II, CEO of New Era Energy & Digital, who is specifically named as a defendant in a fraud lawsuit. The involvement of a CEO in a state-level fraud suit is highly material, as it signals deep governance and operational risk. The narrative fits a legal risk alert rather than an investor relations strategy, and there is no evidence of any attempt by the companies to counter these allegations or communicate directly with shareholders in this context.

What the data suggests

The announcement provides no financial statements, revenue figures, profit margins, cash flow data, or operational metrics for any of the companies involved. The only concrete data points are the dates of alleged misconduct or legal actions: for example, a research report on March 24, 2026, challenged ADMA’s reported growth, and on December 29, 2025, the New Mexico Attorney General filed suit against New Era and its CEO. There are no period-over-period numbers, no guidance, and no evidence of whether any company has met or missed prior targets. The gap between the legal claims and the available data is total—there is simply no quantitative evidence provided to support or refute the allegations. The disclosures are incomplete to the point of opacity; key metrics such as revenue, EBITDA, cash burn, or even basic balance sheet health are entirely absent. An independent analyst, relying solely on this announcement, would conclude that the companies are facing severe legal and reputational headwinds, but would be unable to assess their financial health, growth trajectory, or investment merit. The lack of transparency is itself a red flag, as it prevents any meaningful financial analysis or risk assessment.

Analysis

The announcement is a legal notice regarding investigations and lawsuits against several NASDAQ-listed companies for alleged misconduct, including misleading disclosures and inadequate internal controls. There are no realised operational or financial achievements disclosed, nor are there any forward-looking business projections or promotional claims about future performance. The only forward-looking statements relate to potential corporate reforms or improvements, but these are not presented as company achievements or milestones. No capital outlays or investment programs are described, and there is no discussion of timelines for benefit realisation. The tone is negative, but the content is factual and legalistic, not promotional or exaggerated. The gap between narrative and evidence is minimal, as the announcement does not attempt to inflate company prospects or achievements.

Risk flags

• ●Legal risk is acute: multiple companies are under investigation or subject to lawsuits for alleged breaches of fiduciary duty, misleading disclosures, and fraudulent conduct. This exposes investors to the possibility of regulatory sanctions, financial penalties, and even delisting.
• ●Disclosure risk is extreme: the announcement contains no financial or operational data, making it impossible for investors to assess the companies’ true performance or risk profile. This lack of transparency is a major red flag.
• ●Operational risk is high: allegations include channel-stuffing, undisclosed related-party transactions, and overstated progress on major projects. If substantiated, these practices could indicate systemic management failures and unreliable reporting.
• ●Reputational risk is material: public lawsuits and investigations, especially those involving state attorneys general and company CEOs, can severely damage a company’s standing with customers, partners, and capital markets.
• ●Execution risk is severe: any potential reforms or improvements are contingent on lengthy legal processes, with no guarantee of a positive outcome for shareholders. The timeline to resolution is long and uncertain.
• ●Pattern-based risk is evident: multiple companies in the announcement are accused of similar governance and disclosure failures, suggesting a broader sectoral or market risk for investors in these types of small-cap or speculative NASDAQ listings.
• ●Forward-looking risk is high: most positive statements are hypothetical, relating to possible future reforms or project progress, but there is no evidence these will materialize or deliver value to shareholders.
• ●Key person risk is present: the CEO of New Era Energy & Digital is named as a defendant in a fraud lawsuit, raising the risk of leadership disruption, further legal exposure, and loss of investor confidence.

Bottom line

For investors, this announcement is a clear warning signal rather than an actionable opportunity. The only substantive information disclosed is the existence of legal investigations and lawsuits targeting multiple NASDAQ-listed companies for alleged misconduct, with no financial or operational data provided to balance or contextualize these risks. The narrative is credible in the sense that it is grounded in public legal actions and specific allegations, but it offers no evidence of business strength, growth, or turnaround potential. The involvement of a CEO as a named defendant in a fraud suit is particularly damaging, but it does not guarantee any specific outcome—legal processes are slow, and settlements or reforms may not benefit existing shareholders. To change this assessment, the companies would need to disclose detailed, audited financials, operational milestones, and concrete evidence of governance reforms or business progress. Investors should watch for court filings, regulatory updates, and any future disclosures of financial results or independent audit findings. At present, this announcement is not a signal to buy or even to monitor for upside; it is a strong caution to reassess exposure and consider risk mitigation. The single most important takeaway is that legal and governance risks are front and center, and in the absence of financial transparency, investors should assume the worst until proven otherwise.

Announcement summary

(NASDAQ: ADMA) Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. breached their fiduciary duties to the company and its shareholders, specifically regarding internal controls and revenue recognition practices. The investigation alleges that ADMA failed to disclose certain related-party transactions, engaged in channel-stuffing activities, and made materially misleading statements about internal controls and financial reporting. On March 24, 2026, a research report publicly challenged ADMA's reported growth and alleged materially overstated revenue growth and substantial product inventory accumulation. (NASDAQ: WGS) Grabar Law Office is also investigating claims that GeneDx Holdings Corp. executives made false and/or misleading statements about the impact of the Fabric acquisition, allegedly disregarding significant problems in Fabric’s viability. (NASDAQ: NAVN) Navan, Inc. is under investigation for allegedly omitting material information in its October 30, 2025 IPO documents, including decelerating revenue growth and increased sales and marketing spending. (NASDAQ: NUAI) New Era Energy & Digital, Inc. (formerly New Era Helium (NASDAQ: NEHC)) is alleged to have made false statements about its Texas Critical Data Centers project and permitting progress, with reports of a lawsuit filed by the New Mexico Attorney General on December 29, 2025, alleging a fraudulent oil-and-gas scheme. The company is accused of transferring wells among affiliated entities to evade environmental liabilities. The companies project or represent ongoing progress or improvements in their respective business operations, but these are challenged by the investigations and lawsuits described.

Disagree with this article?